Gaurav Shah is the Chief Executive Officer of Rocket Pharmaceuticals. Funding history, background and contact routes on StartupFundraising.com.
Gaurav Shah is the Chief Executive Officer of Rocket Pharmaceuticals. Under his leadership, Rocket Pharmaceuticals acquired Renovacor, a biotechnology company specializing in therapies for genetically-driven cardiovascular diseases. This acquisition aimed to expand Rocket's leadership in AAV-based gene therapy for cardiac diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library